# A Study of AMG 114 Administered by Subcutaneous Injection for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies Receiving Multicycle Chemotherapy

> **NCT00119600** · PHASE1,PHASE2 · TERMINATED · sponsor: **Amgen**

## Conditions studied

- Anemia
- Cancer

## Interventions

- **DRUG:** AMG 114

## Key facts

- **NCT ID:** NCT00119600
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2009-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00119600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00119600, "A Study of AMG 114 Administered by Subcutaneous Injection for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies Receiving Multicycle Chemotherapy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00119600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*